J Kelly - Arthritis Rheum, 2011 - medscape.com August 31, 2011 — A new set of evidence-based guidelines provides an algorithm for reducing colchicine doses to prevent toxicity in patients who are also taking drugs such as cyclosporine, ketoconazole, ritonavir, clarithromycin, azithromycin, verapamil extended ...
RA Terkeltaub, DE Furst, JL DiGiacinto… - Arthritis & …, 2011 - Wiley Online Library The ratios of the maximum concentration and area under the curve from time 0 to infinity for colchicine plus CYP3A4/P-glycoprotein inhibitors versus colchicine alone were >125% across all studies, with the exception of studies involving azithromycin. Significant DDIs were ...
J Leung, PA Bonis… - Clinical gastroenterology and …, 2011 - ncbi.nlm.nih.gov BACKGROUND & AIMS: The combination of ursodeoxycholic acid (UDCA), colchicine, and methotrexate (MTX) is effective therapy for a subset of patients with primary biliary cirrhosis (PBC) who do not respond to UDCA. However, the durability of the response is unclear. We investigated ... All 2 versions
K Yildirim, H Uzkeser, A Uyanik, S Karatay… - …, 2011 - Br Soc Rheumatology Background: The aim of this study was to determine the alterations in serum copper (Cu), zinc (Zn) and selenium (Se) levels in Familial Mediterranean Fever (FMF) patients as compared to healthy controls. ... Methods: This study was conducted on 33 patients with FMF during ...
MW Davis, S Wason… - Journal of the American …, 2011 - Am Coll Cardio Found ... Cardiol. Matthew W. Davis, Suman Wason, and Jennifer DiGiacinto DOSE UNDER FASTED CONDITIONS ADMINISTERED TO HEALTHY ADULT SUBJECTS AS A SINGLE 0.6-MG SINGLE-DOSE PHARMACOKINETICS OF COLCHICINE THE EFFECT OF MULTIPLE DOSE ... All 2 versions